Related Experiment Video
Updated: Mar 19, 2026

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Transferable resistance to colistin: a new but old threat
Stefan Schwarz1, Alan P Johnson2
1Institute of Farm Animal Genetics, Friedrich-Loeffler-Institut (FLI), Neustadt-Mariensee, Germany stefan.schwarz@fli.bund.de.
Abstract:
In this Leading article, we summarize current knowledge of the occurrence of the first and so far only transferable colistin resistance gene, mcr-1 Its location on a conjugative plasmid is likely to have driven its spread into a range of enteric bacteria in humans and animals. Screening studies have identified mcr-1 in five of the seven continents and retrospective studies in China have identified this gene in Escherichia coli originally isolated in the 1980s, while the first European isolate dates back to 2005. Based on the widespread use of colistin in pigs and poultry in several countries and the higher number of mcr-1-carrying isolates of animal origin than of human origin, it is tempting to assume that this resistance may have emerged in the animal sector. Whatever its origin, interventions to reduce its further spread will require an integrated global one-health approach, comprising robust antibiotic stewardship to reduce unnecessary colistin use, improved infection prevention, and control and surveillance of colistin usage and resistance in both veterinary and human medicine.
Insights
The transferable colistin resistance gene, mcr-1, has spread globally in human and animal enteric bacteria. Reducing its spread requires a unified "One Health" strategy focusing on antibiotic stewardship and surveillance.
Area of Science:
- Microbiology
- Antimicrobial Resistance
- Public Health
Background:
- The emergence and global dissemination of antimicrobial resistance genes pose a significant threat to public health.
- Colistin is a critical antibiotic for treating multidrug-resistant Gram-negative infections.
- The mcr-1 gene confers transferable resistance to colistin, raising concerns about its spread.
Purpose of the Study:
- To summarize current knowledge on the occurrence and spread of the mcr-1 gene.
- To explore the potential origins and transmission routes of mcr-1.
- To highlight the need for a global One Health approach to combat colistin resistance.
Main Methods:
- Review of existing literature and screening studies on mcr-1 prevalence.
- Analysis of isolate data from human and animal sources across different continents.
- Retrospective analysis of historical isolate data.
Main Results:
- The mcr-1 gene has been detected on five continents in various enteric bacteria.
- mcr-1 has been identified in Escherichia coli dating back to the 1980s in China and 2005 in Europe.
- Isolates carrying mcr-1 are more frequently found in animals than in humans, suggesting a potential animal origin.
Conclusions:
- The conjugative plasmid location of mcr-1 facilitates its rapid spread.
- The animal sector may be a significant reservoir for mcr-1 emergence and dissemination.
- Integrated global One Health strategies, including antibiotic stewardship and enhanced surveillance, are crucial to mitigate the spread of colistin resistance.
Related Concept Videos
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Antibiotic Selection
Repressible Operon: trp Operon
Transduction

